These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1823998)

  • 1. Influences of Polyactin A on activities of human monocytes in vitro.
    Hu QL; Wang H; Wang YS; Chen RX; Shen WM; Wang P
    Zhongguo Yao Li Xue Bao; 1991 Nov; 12(6):483-8. PubMed ID: 1823998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of a novel immunopotentiator polyactin A on interleukin 1 production and responsiveness in mice.
    Hu QL; Wang H; Wang YS; Shen WM; Chen RX; Wang P
    Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):135-40. PubMed ID: 1776477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.
    Herman J; Dinarello CA; Kew MC; Rabson AR
    J Immunol; 1985 Oct; 135(4):2882-6. PubMed ID: 2993420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes.
    Bloom ET; Babbitt JT
    Nat Immun Cell Growth Regul; 1990; 9(1):36-48. PubMed ID: 2139495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-beta 2/IL-6 augments the activity of human natural killer cells.
    Luger TA; Krutmann J; Kirnbauer R; Urbanski A; Schwarz T; Klappacher G; Köck A; Micksche M; Malejczyk J; Schauer E
    J Immunol; 1989 Aug; 143(4):1206-9. PubMed ID: 2787359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction.
    Atedzoe BN; Ahmad A; Menezes J
    J Immunol; 1997 Nov; 159(10):4966-72. PubMed ID: 9366423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET; Babbitt JT; Kawakami K
    J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimetastatic action of polyactin A and its mechanism].
    Qiang WA; Liu JR; Wang YS; Lei YD
    Yao Xue Xue Bao; 1994; 29(5):340-5. PubMed ID: 7976351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-activated NK cells trigger monocyte oxidative metabolism.
    Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
    J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
    J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins.
    Voiculescu CL; Rosu L; Rogoz S
    Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.